Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)
Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
Chronic hepatitis C is a liver disease related to a virus: hepatitis C virus (HCV). The type
of HCV present in Egypt (genotype 4), has the reputation to respond poorly to Interferon
treatment at the chronic stage. Pegylated Interferon is a new form of Interferon that stays
in the body for longer time and allows the patient to take less injection per week. It has
proved to be more effective than standard Interferon. The combination of two drugs,
Interferon and Ribavirin, is considered to be the best treatment available for chronic
hepatitis C.
Phase:
Phase 3
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis